Haploidentical transplantation for leukemia.

Haploidentical transplantation for leukemia.
复制标题

DOI:
10.1007/s11912-010-0113-4
复制
发表时间:
2010-09
影响因子:
4.7
通讯作者:
Rizzieri, David A.
Rizzieri, David A.
中科院分区:
医学2区
文献类型:
--
作者:
Kanda, Junya;Chao, Nelson J.;Rizzieri, David A.

文献摘要

参考文献

被引文献

相似文献

人类白细胞抗原(人类白细胞抗原)半相合家庭成员的造血干细胞移植为需要异基因免疫治疗的患者提供了一种潜在的治疗方法,这些患者无法立即获得HLA匹配的捐赠者。使用体外T细胞耗尽的干细胞和免疫清髓调节相结合,使持久的供者植入与低发生率的急性移植物抗宿主疾病,尽管有人类白细胞抗原的差异。此外,涉及体内T细胞耗尽和低强度调节的额外移植技术进一步将风险降至最低。然而,一个主要的缺点是免疫重建延迟导致感染和高复发率,促使大量研究努力集中在改善移植后时期的恢复上。与捐献者淋巴细胞输注是很常见的,尽管专注于捐赠者自然杀伤细胞的新操作有很大的希望,其他改良的捐赠者T细胞输注也是如此。这些新程序的成功将使单倍体相合移植更安全、更有效,进一步扩大其吸引力。
Hematopoietic stem cell transplantation from human leukocyte antigen (HLA)-haploidentical family members offers a potential cure for patients in need of allogeneic immunotherapy who have no immediate access to an HLA-matched donor. The use of ex vivo T-cell-depleted stem cells combined with immuno-myeloablative conditioning has enabled durable donor engraftment with a low incidence of acute graft-versus-host disease despite the HLA disparity. Moreover, additional transplant techniques involving in vivo T-cell-depletion and reduced-intensity conditioning have further minimized the risks. However, a major drawback is delayed immune reconstitution leading to infections and high relapse rates, prompting significant research efforts focused on improving recovery in the post-transplant period. Infusions with donor lymphocytes are common, though newer manipulations with a focus on donor natural killer cells hold great promise as does other modified donor T-cell infusions. Success of these new procedures will make haploidentical transplants safer and more effective, further broadening its appeal.
DOI: 10.1182/blood.v89.10.3864.3864_3864_3872
发表时间: 1997-05-15
期刊: BLOOD
影响因子: 20.3
作者:
HensleeDowney, PJ;Abhyankar, SH;Gee, AP
通讯作者: Gee, AP
DOI: 10.1200/jco.2005.09.117
发表时间: 2005-05-20
影响因子: 45.3
作者:
Aversa, F;Terenzi, A;Martelli, MF
通讯作者: Martelli, MF
使用未操作的 HLA 不匹配/半相合血液和骨髓移植治疗急性白血病。
DOI: 10.1016/j.bbmt.2008.11.025
发表时间: 2009-02-01
影响因子: 4.3
作者:
Huang, Xiao-Jun;Liu, Dai-Hong;Lu, Dao-Pei
通讯作者: Lu, Dao-Pei
DOI: 10.1056/nejmoa041276
发表时间: 2004-11-25
影响因子: 158.5
作者:
Laughlin, MJ;Eapen, M;Horowitz, MM
通讯作者: Horowitz, MM
DOI: 10.1016/j.bcmd.2007.07.001
发表时间: 2008-01-01
影响因子: 2.3
作者:
Bethge, Wolfgang A.;Faul, Christoph;Kanz, Lothar
通讯作者: Kanz, Lothar